Cardiff Oncology, Inc. (CRDF)
0.989
0.00 (0.00%)
USD |
NASDAQ |
Aug 27, 16:00
0.989
0.00 (0.00%)
After-Hours: 19:27
Cardiff Oncology EPS Diluted (TTM) : -0.5906 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5906 |
| March 31, 2026 | -0.6652 |
| December 31, 2025 | -0.6865 |
| September 30, 2025 | -0.7936 |
| June 30, 2025 | -0.8783 |
| March 31, 2025 | -0.9315 |
| December 31, 2024 | -0.9537 |
| September 30, 2024 | -0.9493 |
| June 30, 2024 | -0.9141 |
| March 31, 2024 | -0.9009 |
| December 31, 2023 | -0.928 |
| September 30, 2023 | -0.9137 |
| June 30, 2023 | -0.8937 |
| March 31, 2023 | -0.8853 |
| December 31, 2022 | -0.8884 |
| September 30, 2022 | -0.9263 |
| June 30, 2022 | -0.9033 |
| March 31, 2022 | -0.8365 |
| December 31, 2021 | -0.7216 |
| September 30, 2021 | -0.6746 |
| June 30, 2021 | -0.6926 |
| March 31, 2021 | -1.028 |
| December 31, 2020 | -1.302 |
| September 30, 2020 | -1.627 |
| June 30, 2020 | -2.146 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.400 |
| December 31, 2019 | -3.009 |
| September 30, 2019 | -3.586 |
| June 30, 2019 | -3.972 |
| March 31, 2019 | -8.488 |
| December 31, 2018 | -13.70 |
| September 30, 2018 | -16.93 |
| June 30, 2018 | -24.47 |
| March 31, 2018 | -37.91 |
| December 31, 2017 | -54.72 |
| September 30, 2017 | -74.88 |
| June 30, 2017 | -90.72 |
| March 31, 2017 | -96.48 |
| December 31, 2016 | -99.36 |
| September 30, 2016 | -93.60 |
| June 30, 2016 | -85.68 |
| March 31, 2016 | -90.72 |
| December 31, 2015 | -88.56 |
| September 30, 2015 | -87.84 |
| June 30, 2015 | -91.44 |
| March 31, 2015 | -66.24 |
| December 31, 2014 | -54.72 |
| September 30, 2014 | -40.32 |
| June 30, 2014 | -38.16 |
| March 31, 2014 | -58.32 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Ocugen, Inc. | -0.2547 |
| CytomX Therapeutics, Inc. | -0.4569 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Anika Therapeutics, Inc. | -0.2741 |